SBN 0.00% 0.0¢ sun biomedical limited

Ann: Sun Biomedical Completes First Phase of Oraline Testing, page-13

  1. 3,675 Posts.
    lightbulb Created with Sketch. 555
    With the right announcement this could easily see 100-200% gains. That would still only put this at a market cap of about $9m.

    Patience needed. Even the equiv. pre-consol price is only 1.4c so that is an obvious short-term target. Hate to think what the average price of long-term holders is tho.
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.